Biochemical characterization of GSK1070916, a potent and selective inhibitor of Aurora B kinase with an extremely slow off-rate.
Jingsong Yang(South College), Zhihong Lai(South College), Jerry L. Adams(Molecular Oncology (United States)), Denis R. Patrick(Molecular Oncology (United States)), Octerloney B. McDonald, Mary Ann Hardwicke(GlaxoSmithKline (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Kelly Anderson(South College), K. A. NEWLANDER(South College), Robert Copeland(Howard University), Domingos Silva(South College)
Cancer Research
May 1, 2008
Cited by 0
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550